In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Concentrix Corp (NASDAQ: CNXC) closed at $41.69 up 3.68% from its previous closing price of $40.21. In other words, the price has increased by $3.68 from its previous closing price. On the day, 0.55 million shares were traded. CNXC stock price reached its highest trading level at $41.789 during the session, while it also had its lowest trading level at $40.2.
Ratios:
For a deeper understanding of Concentrix Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.82 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.03. For the most recent quarter (mrq), Quick Ratio is recorded 1.56 and its Current Ratio is at 1.56. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.25.
Upgrades & Downgrades
In the most recent recommendation for this company, Barrington Research on March 24, 2025, Reiterated its Outperform rating but revised its target price to $54 from $70 previously.
On October 03, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $70.
BofA Securities Upgraded its Underperform to Neutral on August 28, 2024, whereas the target price for the stock was revised from $65 to $85.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 28 ’25 when Twomey Cormac J sold 500 shares for $35.50 per share. The transaction valued at 17,750 led to the insider holds 35,130 shares of the business.
CORMAC TWOMEY bought 500 shares of CNXC for $17,750 on Nov 28 ’25. On Oct 31 ’25, another insider, Caldwell Christopher A, who serves as the President and CEO of the company, bought 1,000 shares for $40.00 each. As a result, the insider paid 40,000 and bolstered with 287,661 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNXC now has a Market Capitalization of 2627517184 and an Enterprise Value of 7991762432. As of this moment, Concentrix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 8.81, and their Forward P/E ratio for the next fiscal year is 3.40. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.49. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.27 while its Price-to-Book (P/B) ratio in mrq is 0.60. Its current Enterprise Value per Revenue stands at 0.822 whereas that against EBITDA is 5.796.
Stock Price History:
The Beta on a monthly basis for CNXC is 0.50, which has changed by -0.061881185 over the last 52 weeks, in comparison to a change of 0.16098404 over the same period for the S&P500. Over the past 52 weeks, CNXC has reached a high of $66.00, while it has fallen to a 52-week low of $31.62. The 50-Day Moving Average of the stock is 6.42%, while the 200-Day Moving Average is calculated to be -14.86%.
Shares Statistics:
For the past three months, CNXC has traded an average of 1.06M shares per day and 937330 over the past ten days. A total of 62.21M shares are outstanding, with a floating share count of 43.53M. Insiders hold about 30.08% of the company’s shares, while institutions hold 85.23% stake in the company. Shares short for CNXC as of 1765756800 were 8210597 with a Short Ratio of 7.76, compared to 1763078400 on 7868680. Therefore, it implies a Short% of Shares Outstanding of 8210597 and a Short% of Float of 15.909999999999998.
Dividends & Splits
According to the company, the forward annual dividend rate for CNXC is 1.36, from 1.331 in the trailing year. Against a Trailing Annual Dividend Yield of 0.03310122
Earnings Estimates
. The current rating of Concentrix Corp (CNXC) reflects the combined expertise of 4.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $2.9, with high estimates of $3.01 and low estimates of $2.75.
Analysts are recommending an EPS of between $12.2 and $11.12 for the fiscal current year, implying an average EPS of $11.37. EPS for the following year is $12.25, with 5.0 analysts recommending between $13.04 and $11.93.
Revenue Estimates
A total of 4 analysts believe the company’s revenue will be $2.54B this quarter.It ranges from a high estimate of $2.55B to a low estimate of $2.53B. As of. The current estimate, Concentrix Corp’s year-ago sales were $2.45BFor the next quarter, 4 analysts are estimating revenue of $2.49B. There is a high estimate of $2.53B for the next quarter, whereas the lowest estimate is $2.46B.
A total of 5 analysts have provided revenue estimates for CNXC’s current fiscal year. The highest revenue estimate was $9.82B, while the lowest revenue estimate was $9.79B, resulting in an average revenue estimate of $9.81B. In the same quarter a year ago, actual revenue was $9.62BBased on 5 analysts’ estimates, the company’s revenue will be $10.12B in the next fiscal year. The high estimate is $10.28B and the low estimate is $10.02B.
